Clinical Trial Update: Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring ENBREL (etanercept) for resistant Langerhans cell histiocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Histiocytosis, Langerhans-Cell | Phase 2 | Status: COMPLETED